{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:38:40Z","timestamp":1791092320808,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:p>\n            Chronic administration of aldosterone promotes myocardial fibrosis in rats. The Randomized Aldactone Evaluation Study reported that the aldosterone antagonist spironolactone improved outcome in patients with congestive heart failure, suggesting a deleterious effect of aldosterone in the heart. Aldosterone has been shown to have rapid nongenomic effects in different tissues including the heart. However, the hemodynamic actions of aldosterone and spironolactone are not well characterized. In this study, we examined the hemodynamic effects of aldosterone and its receptor antagonist, spironolactone, in the isolated rat heart by use of the Langendorff-Neely technique. Perfusion with 10 nmol\/L aldosterone increased contractility by 45% within 2 to 4 minutes (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01). Similar to the aldosterone effect, 10 nmol\/L spironolactone increased contractility by 41% (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01). Furthermore, 100-fold molar excess of spironolactone did not block the aldosterone effect. Perfusion of aldosterone plus spironolactone resulted in the highest increase in contractility 106% (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01). The threshold response for aldosterone occurred within physiological concentrations (0.5 to 1 nmol\/L), and maximal contractility was achieved with 10 nmol\/L aldosterone. For spironolactone, the threshold and maximal contractile responses occurred at concentrations readily achieved with clinical dosing, 0.1 to 0.5 nmol\/L and 1.0 nmol\/L, respectively. These data demonstrate that aldosterone and spironolactone have rapid, positive inotropic actions on the myocardium. Moreover, addition of spironolactone to aldosterone increased contractility beyond the maximal responses elicited by each agent when perfused alone, thus suggesting different pathways of action. Furthermore, the intrinsic inotropic effects of spironolactone might be relevant to the apparent beneficial effect this compound has in patients with congestive heart failure.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000025879.29822.24","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:44:29Z","timestamp":1033508669000},"page":"130-135","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Rapid Effects of Aldosterone and Spironolactone in the Isolated Working Rat Heart"],"prefix":"10.1161","volume":"40","author":[{"given":"John C.","family":"Barbato","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Medical College of Ohio, Toledo."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Mulrow","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Medical College of Ohio, Toledo."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Medical College of Ohio, Toledo."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Franco-Saenz","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Medical College of Ohio, Toledo."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.63.3.7006851"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00795367"},{"key":"e_1_3_1_3_2","first-page":"330","volume":"20","year":"1995","unstructured":"Funck RC, Wilke A, Rupp H, Maisch B, Brilla CG. Cardiac structure: function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease. Herz. 1995; 20: 330\u2013339.","journal-title":"Herz"},{"key":"e_1_3_1_4_2","first-page":"I-389","volume":"39","year":"1994","unstructured":"Brilla CG, Rupp H. Myocardial collagen matrix remodeling and congestive heart failure. Cardiologia. 1994; 39 (suppl I): I-389\u2013I-93.","journal-title":"Cardiologia"},{"key":"e_1_3_1_5_2","first-page":"S210.","volume":"9","year":"1994","unstructured":"Brilla CG. The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure. Curr Opin Cardiol. 1994; 9: S210.Abstract.","journal-title":"Curr Opin Cardiol"},{"key":"e_1_3_1_6_2","first-page":"O-107","volume":"16","year":"1995","unstructured":"Brilla CG, Rupp H, Funck R, Maisch B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodeling in congestive heart failure. Eur Heart J. 1995; 16 (suppl O): O-107\u2013O-109.","journal-title":"Eur Heart J"},{"key":"e_1_3_1_7_2","first-page":"8","volume":"15","year":"2000","unstructured":"Zannad F. Anti-aldosterone: the evidence of the RALES study. Arch Mal Coeur Vaiss. 2000; 15: 8\u20139.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1024\/0040-5930.57.6.374"},{"key":"e_1_3_1_9_2","first-page":"I-67","volume":"8","year":"1993","unstructured":"Barsotti A, Dini FL, Nardini V, Di Muzio M, Gallina S, Di Napoli P, Calafiore AM, Trevi G. From myocardial hypertrophy to heart failure: role of the interstitium. Cardiologia. 1993; 8 (suppl I): I-67\u2013I-77.","journal-title":"Cardiologia"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00926359"},{"key":"e_1_3_1_11_2","first-page":"II-10","volume":"6","year":"1993","unstructured":"Weber KT, Brilla CG. Structural basis for pathologic left ventricular hypertrophy. Clin Cardiol. 1993; 6 (suppl II): II-10\u2013II-14.","journal-title":"Clin Cardiol"},{"key":"e_1_3_1_12_2","first-page":"II-14","volume":"17","year":"1991","unstructured":"Weber KT, Brilla CG, Janicki JS. Signals for the remodeling of the cardiac interstitium in systemic hypertension. J Cardiovasc Pharmacol. 1991; 17 (suppl II): II-14\u2013II-19.","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.83.6.1828192"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","volume":"71","year":"1993","unstructured":"Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol. 1993; 71: 12A\u201316A.","journal-title":"Am J Cardiol"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00088-7"},{"key":"e_1_3_1_16_2","first-page":"147","volume":"22","year":"1963","unstructured":"Tanz RD. Inotropic effects of certain steroids upon the heart muscle. Rev Can Biol. 1963; 22: 147\u2013163.","journal-title":"Rev Can Biol"},{"key":"e_1_3_1_17_2","first-page":"71","volume":"135","year":"1962","unstructured":"Tanz RD. Studies on the inotropic actions of aldosterone on isolated cardiac tissue preparations, including the effects of pH, ouabain and SC-8109. J Pharmacol Exp Ther. 1962; 135: 71\u201378.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1995.0239"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.35.5.1099"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(92)90092-K"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(94)00027-A"},{"key":"e_1_3_1_22_2","first-page":"338","volume":"36","year":"1995","unstructured":"Wehling M, Scriba PC. Non-genomic aldosterone action: a new concept for the mechanism of action of steroids is developed. Internist. 1995; 36: 338\u2013342.","journal-title":"Internist"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00674.x"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1998.255bi.x"},{"key":"e_1_3_1_25_2","first-page":"805","volume":"45","year":"1999","unstructured":"Manegold JC, Falkenstein E, Wehling M, Christ M. Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell Mol Biol. 1999; 45: 805\u2013813.","journal-title":"Cell Mol Biol"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702036"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703193"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002329900534"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)88565-8"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.76.6.973"},{"key":"e_1_3_1_31_2","first-page":"1452","volume":"77","year":"1993","unstructured":"Christ M, Eisen C, Aktas J, Theisen Wehling M. The inositol-1,4,5-triphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes. J Clin Endocrinol Metab. 1993; 77: 1452\u20131457.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.8.5352"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139412"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01725704"},{"key":"e_1_3_1_35_2","first-page":"784","volume":"217","year":"1981","unstructured":"Finotti P, Palatini P. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase. J Pharmacol Exp Ther. 1981; 217: 784\u2013790.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1967.212.4.804"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1998.85.2.530"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00367.2001"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.85.12.1139"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8719(97)00020-8"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01046-8"},{"key":"e_1_3_1_42_2","first-page":"1161","volume":"127","year":"1959","unstructured":"Briggs AH, Holland WC. Antifibrillatory effects of electrolytes regulating steroids on isolated rabbit atria. Am J Physiol. 1959; 127: 1161\u20131164.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_43_2","first-page":"150","volume":"166","year":"1997","unstructured":"Bacciarelli C. The effects of digoxin, desoxycorticosterone and spironolactone on the myocardium of the mammal. Arch Int Pharmacodyn Ther. 1997; 166: 150\u2013166.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.5.943"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1989.tb02861.x"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.9.4883"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000025879.29822.24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:44:54Z","timestamp":1715532294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000025879.29822.24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1161\/01.HYP.0000025879.29822.24"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000025879.29822.24","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"2002-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-06-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}